Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-036828
Filing Date
2025-02-26
Accepted
2025-02-26 16:44:42
Documents
17
Effectiveness Date
2025-02-26

Document Format Files

Seq Description Document Type Size
1 S-8 d930835ds8.htm S-8 45883
2 EX-5.1 d930835dex51.htm EX-5.1 13324
3 EX-23.1 d930835dex231.htm EX-23.1 1522
4 EX-FILING FEES d930835dexfilingfees.htm   iXBRL EX-FILING FEES 33337
5 GRAPHIC g930835dsp07.jpg GRAPHIC 11965
6 GRAPHIC g930835dsp8.jpg GRAPHIC 8265
  Complete submission text file 0001193125-25-036828.txt   271423

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d930835dexfilingfees_htm.xml XML 13311
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285285 | Film No.: 25670857
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)